| 01/02/22 | 07:00:04 | 1 Feb 2022 | | Update to agreement with Sio Gene Therapies |
| 31/01/22 | 11:21:05 | 31 Jan 2022 | | Market Share Purchase |
| 28/01/22 | 17:59:00 | 28 Jan 2022 | | Result of Placing and PrimaryBid offer |
| 28/01/22 | 14:04:43 | 28 Jan 2022 | | Holdings in Company |
| 28/01/22 | 07:38:22 | 28 Jan 2022 | | Retail offer by PrimaryBid |
| 28/01/22 | 07:24:37 | 28 Jan 2022 | | US Agreement and Proposed Placing of Shares |
| 17/01/22 | 07:00:08 | 17 Jan 2022 | | John Dawson to retire from Oxford Biomedica |
| 05/01/22 | 07:00:07 | 5 Jan 2022 | | Oxford Biomedica Agreement with Cabaletta Bio |
| 04/01/22 | 11:07:19 | 4 Jan 2022 | | Block listing Return |
| 04/01/22 | 10:32:44 | 4 Jan 2022 | | Total Voting Rights |
| 04/01/22 | 07:00:13 | 4 Jan 2022 | | John Dawson awarded CBE in New Year Honours List |
| 14/12/21 | 07:00:11 | 14 Dec 2021 | | Board Appointment |
| 13/12/21 | 07:00:08 | 13 Dec 2021 | | Oxford Biomedica Updates Lentiviral Agreement |
| 13/12/21 | 07:00:08 | 13 Dec 2021 | | Oxford Biomedica Signs Agreement with Arcellx |
| 01/12/21 | 09:49:53 | 1 Dec 2021 | | Total Voting Rights |
| 01/11/21 | 10:08:24 | 1 Nov 2021 | | Long Term Incentive Plan Option Grant |
| 01/11/21 | 10:02:34 | 1 Nov 2021 | | Total Voting Rights |
| 19/10/21 | 07:00:07 | 19 Oct 2021 | | Boehringer Ingelheim Exercises Option |
| 01/10/21 | 09:51:25 | 1 Oct 2021 | | Total Voting Rights |
| 29/09/21 | 17:54:43 | 29 Sept 2021 | | Holding(s) in Company |
| 29/09/21 | 17:36:09 | 29 Sept 2021 | | Directors Dealings / Market Share Purchases |
| 28/09/21 | 16:48:49 | 28 Sept 2021 | | Holding(s) in Company |
| 28/09/21 | 10:01:30 | 28 Sept 2021 | | Total Voting Rights |
| 22/09/21 | 07:38:10 | 22 Sept 2021 | | Strategic investment by Serum Life Sciences |
| 22/09/21 | 07:00:04 | 22 Sept 2021 | | Interim Results |
| 01/09/21 | 10:48:41 | 1 Sept 2021 | | Total Voting Rights |
| 01/09/21 | 07:00:10 | 1 Sept 2021 | | Notice of Interim Results |
